Further certification attained against Clostridium Difficile from Campden BRI
29th August 2011
With new figures showing worrying increases in C difficile associated deaths in hospitals, Cleanitise with it’s 99.999% effective germkill can make a difference in the healthcare market.
We requested that Campden Technology Limited (Campden BRI) assess the efficacy of Cleanitise for sporicidal activity against C. difficile using the method BSEN 13704:2002 and were delighted to receive their report:
EN 13704:2002, Chemical disinfectants – Quantitative suspension test for the evaluation of sporicidal activity of chemical disinfectants used in food, industrial, domestic and institutional areas. To assess the efficacy of Cleanitise for sporicidal activity against Clostridium Difficile
Download Report MB:REP:123672:1
A further 21 certificates of analysis for Cleanitise can be viewed here.